Diabetic Macular Edema (DME)
Symptoms, Doctors, Treatments, Advances & More

Diabetic Macular Edema (DME) Overview

Save information for later
Sign Up

Learn About Diabetic Macular Edema (DME)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Diabetic Macular Edema (DME) Local Doctors?
Elite in Diabetic Macular Edema (DME)
Ophthalmology
Elite in Diabetic Macular Edema (DME)
Ophthalmology

Joslin Diabetes Center

1 Joslin Place, 
Boston, MA 
Languages Spoken:
English

Jennifer Sun is an Ophthalmologist practicing medicine in Boston, Massachusetts. Dr. Sun is rated as an Elite provider by MediFind in the treatment of Diabetic Macular Edema (DME). She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Diabetic Retinopathy, Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal. Dr. Sun is board certified in American Board Of Ophthalmology.

Elite in Diabetic Macular Edema (DME)
Ophthalmology
Elite in Diabetic Macular Edema (DME)
Ophthalmology

The Johns Hopkins Hospital

1800 Orleans Street, Maumenee Lobby, Maumenee Lobby, 
Baltimore, MD 
Languages Spoken:
English

Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is rated as an Elite provider by MediFind in the treatment of Diabetic Macular Edema (DME). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal. Dr. Bressler is board certified in American Board Of Ophthalmology.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Diabetic Macular Edema (DME)
Ophthalmology
Elite in Diabetic Macular Edema (DME)
Ophthalmology

Joslin Diabetes Center

1 Joslin Place, 
Boston, MA 
Languages Spoken:
English

Lloyd Aiello is an Ophthalmologist practicing medicine in Boston, Massachusetts. Dr. Aiello is rated as an Elite provider by MediFind in the treatment of Diabetic Macular Edema (DME). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal. Dr. Aiello is board certified in American Board Of Ophthalmology.

What are the latest Diabetic Macular Edema (DME) Clinical Trials?
A Randomised, Double-masked, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Oral BI 1815368 in Participants With Centre-involved Diabetic Macular Edema for 48 Weeks of Treatment (THULITE)

Summary: This study is open to adults 18 and older with an eye condition called diabetic macular edema. People are required to have a specific type of diabetic macular edema called centre-involved diabetic macular edema (CI-DME) to take part. The purpose of this study is to find out whether a medicine called BI 1815368 improves sight in people with CI-DME and to find the most suitable dose. This study has ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Real-World, Long-Term Data Collection to Gain Clinical Insights Into Faricimab (FaReal Study)

Summary: The FaReal study aims to evaluate the effectiveness, safety, clinical insights and treatment patterns in patients treated with faricimab, in neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) in at least one eye, in real-world routine clinical practice over a 2-year patient follow-up period. Additionally, the FaReal study also aims to describe and evaluate health e...